Cisen Pharmaceutical Co., Ltd. (SHA:603367)
China
· Delayed Price · Currency is CNY 15.64
-0.02 (-0.13%)
Apr 30, 2026, 10:55 AM CST
Cisen Pharmaceutical Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 853.84 | 1,212 | 1,161 | 983.39 | 997.95 | 938.98 | Upgrade
|
| Short-Term Investments | - | 461.47 | 357.58 | 154.11 | 236.27 | - | Upgrade
|
| Trading Asset Securities | 2,349 | 1,730 | 1,275 | 1,638 | 1,550 | 1,485 | Upgrade
|
| Cash & Short-Term Investments | 3,203 | 3,403 | 2,794 | 2,775 | 2,784 | 2,424 | Upgrade
|
| Cash Growth | 16.27% | 21.83% | 0.66% | -0.32% | 14.87% | -4.46% | Upgrade
|
| Accounts Receivable | 970.61 | 1,041 | 1,257 | 1,363 | 1,272 | 1,048 | Upgrade
|
| Other Receivables | 7.78 | 0.84 | 0.75 | 4.24 | 9.25 | 11.35 | Upgrade
|
| Receivables | 978.4 | 1,042 | 1,257 | 1,367 | 1,281 | 1,060 | Upgrade
|
| Inventory | 616.29 | 623.69 | 810.43 | 708.22 | 580.43 | 594.65 | Upgrade
|
| Other Current Assets | 618.09 | 140.94 | 100.34 | 119.41 | 99.63 | 66.45 | Upgrade
|
| Total Current Assets | 5,416 | 5,210 | 4,962 | 4,970 | 4,745 | 4,145 | Upgrade
|
| Property, Plant & Equipment | 1,627 | 1,675 | 1,546 | 1,390 | 1,489 | 1,591 | Upgrade
|
| Long-Term Investments | 5.43 | 390.03 | 665.08 | 602.27 | 265.08 | 308.01 | Upgrade
|
| Other Intangible Assets | 194.15 | 196.29 | 203.97 | 211.6 | 213.03 | 210.82 | Upgrade
|
| Long-Term Deferred Tax Assets | 70.18 | 78.34 | 77.41 | 79.83 | 86.72 | 81.65 | Upgrade
|
| Long-Term Deferred Charges | -0.2 | - | 0.47 | 1.91 | 3.86 | 2.05 | Upgrade
|
| Other Long-Term Assets | 343.37 | 47.89 | 99.14 | 81.94 | 12.87 | 25.54 | Upgrade
|
| Total Assets | 7,656 | 7,597 | 7,554 | 7,338 | 6,815 | 6,364 | Upgrade
|
| Accounts Payable | 578.77 | 620.31 | 549.49 | 468.01 | 459.71 | 434.97 | Upgrade
|
| Accrued Expenses | 77.06 | 233.37 | 329.92 | 139.77 | 259.48 | 214.52 | Upgrade
|
| Short-Term Debt | 13.24 | 12.08 | 71.98 | 34.8 | 57.79 | 130 | Upgrade
|
| Current Portion of Long-Term Debt | 2.42 | - | 32.63 | - | - | - | Upgrade
|
| Current Portion of Leases | - | 2.04 | 2.64 | 3.34 | 0.3 | 2.72 | Upgrade
|
| Current Income Taxes Payable | 50.25 | 6.28 | 11.71 | 34.67 | 5.61 | 1.18 | Upgrade
|
| Current Unearned Revenue | 70.27 | 64.35 | 78.11 | 100.16 | 118.78 | 70.05 | Upgrade
|
| Other Current Liabilities | 372.21 | 285.34 | 412.36 | 589.17 | 380.24 | 365.5 | Upgrade
|
| Total Current Liabilities | 1,164 | 1,224 | 1,489 | 1,370 | 1,282 | 1,219 | Upgrade
|
| Long-Term Debt | 23.69 | 25.79 | 7.7 | 128.5 | 100 | - | Upgrade
|
| Long-Term Leases | 2.68 | 3.61 | 0.89 | 4.03 | 0.51 | 10.91 | Upgrade
|
| Long-Term Unearned Revenue | 91.67 | 94.04 | 57.17 | 56.25 | 65.36 | 74.43 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 10.9 | 19.54 | 12.28 | 12.68 | 11.46 | 3.87 | Upgrade
|
| Total Liabilities | 1,293 | 1,367 | 1,567 | 1,571 | 1,459 | 1,308 | Upgrade
|
| Common Stock | 452.75 | 452.75 | 452.75 | 452.78 | 453.31 | 453.33 | Upgrade
|
| Additional Paid-In Capital | 1,934 | 1,934 | 1,929 | 1,919 | 1,913 | 1,863 | Upgrade
|
| Retained Earnings | 3,937 | 3,807 | 3,570 | 3,358 | 2,989 | 2,774 | Upgrade
|
| Treasury Stock | - | - | - | -0.08 | -19.77 | -32.74 | Upgrade
|
| Comprehensive Income & Other | -2.63 | -2.65 | -2.71 | -2.69 | -2.93 | -3.07 | Upgrade
|
| Total Common Equity | 6,322 | 6,191 | 5,950 | 5,727 | 5,332 | 5,055 | Upgrade
|
| Minority Interest | 40.89 | 39.52 | 37.39 | 39.1 | 23.64 | 0.75 | Upgrade
|
| Shareholders' Equity | 6,363 | 6,231 | 5,987 | 5,766 | 5,356 | 5,056 | Upgrade
|
| Total Liabilities & Equity | 7,656 | 7,597 | 7,554 | 7,338 | 6,815 | 6,364 | Upgrade
|
| Total Debt | 42.03 | 43.53 | 115.83 | 170.67 | 158.61 | 143.63 | Upgrade
|
| Net Cash (Debt) | 3,161 | 3,360 | 2,678 | 2,604 | 2,625 | 2,280 | Upgrade
|
| Net Cash Growth | 15.78% | 25.47% | 2.81% | -0.79% | 15.15% | 3.32% | Upgrade
|
| Net Cash Per Share | 6.97 | 7.42 | 5.89 | 5.75 | 5.78 | 5.05 | Upgrade
|
| Filing Date Shares Outstanding | 450.85 | 452.75 | 452.75 | 452.76 | 451.36 | 449.83 | Upgrade
|
| Total Common Shares Outstanding | 450.85 | 452.75 | 452.75 | 452.76 | 451.34 | 449.83 | Upgrade
|
| Working Capital | 4,252 | 3,986 | 3,473 | 3,600 | 3,463 | 2,926 | Upgrade
|
| Book Value Per Share | 14.02 | 13.67 | 13.14 | 12.65 | 11.81 | 11.24 | Upgrade
|
| Tangible Book Value | 6,128 | 5,995 | 5,746 | 5,516 | 5,119 | 4,844 | Upgrade
|
| Tangible Book Value Per Share | 13.59 | 13.24 | 12.69 | 12.18 | 11.34 | 10.77 | Upgrade
|
| Buildings | - | 1,412 | 1,277 | 1,275 | 1,188 | 1,191 | Upgrade
|
| Machinery | - | 2,469 | 2,109 | 2,092 | 1,903 | 1,797 | Upgrade
|
| Construction In Progress | - | 163.6 | 405.8 | 66.68 | 207.17 | 199.71 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.